» Articles » PMID: 7215200

Cadmium Induced Changes in Gluconeogenic Enzymes in Rat Kidney and Liver

Overview
Date 1980 Jan 1
PMID 7215200
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Male Sprague-Dawley rats were administered cadmium chloride 0, 50, 100, 150 and 200 ppm for 30 days. At the end of the treatments, the body weight gains, serum glucose, serum protein, serum glutamic oxalacetic transaminase (SGOT) and serum glutamic pyruvic transaminase (SGPT) were determined. Renal and hepatic key gluconeogenic enzymes; viz., pyruvate carboxylase, phosphoenol pyruvate carboxykinase, fructose-1, 6-diphosphatase and glucose-6-phosphatase were also determined. A significant decrease in body weight gain in rats treated with cadmium was observed. The serum glucose and protein levels were increased in rats receiving cadmium through feed. All four key gluconeogenic enzymes were increased in both kidney and liver tissues of rats treated with cadmium. The present results indicate that cadmium may induce gluconeogenesis from non-carbohydrate sources.

Citing Articles

Pancreas-Liver-Adipose Axis: Target of Environmental Cadmium Exposure Linked to Metabolic Diseases.

Moroni-Gonzalez D, Sarmiento-Ortega V, Diaz A, Brambila E, Trevino S Toxics. 2023; 11(3).

PMID: 36976988 PMC: 10059892. DOI: 10.3390/toxics11030223.


Structural-functional aberrations of erythrocytes in the northern red-backed vole (Clethrionomys rutilus Pallas, 1779) that inhabits the zone of influence of the copper smelter (the Middle Ural).

Orekhova N, Davydova Y, Smirnov G Biometals. 2022; 36(4):847-864.

PMID: 36463375 DOI: 10.1007/s10534-022-00478-2.


Oral Subacute Exposure to Cadmium LOAEL Dose Induces Insulin Resistance and Impairment of the Hormonal and Metabolic Liver-Adipose Axis in Wistar Rats.

Sarmiento-Ortega V, Moroni-Gonzalez D, Diaz A, Eduardo B, Samuel T Biol Trace Elem Res. 2021; 200(10):4370-4384.

PMID: 34846673 DOI: 10.1007/s12011-021-03027-z.


The endocrine disruptor cadmium: a new player in the pathophysiology of metabolic diseases.

Bimonte V, Besharat Z, Antonioni A, Cella V, Lenzi A, Ferretti E J Endocrinol Invest. 2021; 44(7):1363-1377.

PMID: 33501614 DOI: 10.1007/s40618-021-01502-x.


Sodium metavanadate treatment improves glycogen levels in multiple tissues in a model of metabolic syndrome caused by chronic cadmium exposure in Wistar rats.

Sarmiento-Ortega V, Moroni-Gonzalez D, Diaz A, Moran C, Brambila E, Trevino S Biometals. 2021; 34(2):245-258.

PMID: 33389338 DOI: 10.1007/s10534-020-00276-8.